This federal Project Grant award for $1,599,997.00 was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports multiple sclerosis research through a clinical trial to be conducted by the University of Illinois, a major public research university system based in Chicago. The award will fund innovative research efforts over a three-year period from September 1, 2024 to August 31, 2027 to advance treatments and address pressing medical challenges related to multiple sclerosis. As a prominent research institution with extensive federal contracting and grant experience, the University of Illinois will leverage its scientific expertise and research capabilities to deliver critical findings from this clinical trial. The results will contribute to the program's broader objectives of transforming healthcare for military service members and the American public through impactful biomedical research.
Generated 2/25/25, 3:16 AM